Last $1.41 USD
Change Today 0.00 / 0.00%
Volume 479.9K
LFVN On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

lifevantage corp (LFVN) Snapshot

Open
$1.42
Previous Close
$1.41
Day High
$1.44
Day Low
$1.40
52 Week High
07/5/13 - $2.68
52 Week Low
01/31/14 - $1.10
Market Cap
146.6M
Average Volume 10 Days
440.4K
EPS TTM
$0.08
Shares Outstanding
103.9M
EX-Date
--
P/E TM
17.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for LIFEVANTAGE CORP (LFVN)

Related News

No related news articles were found.

lifevantage corp (LFVN) Related Businessweek News

No Related Businessweek News Found

lifevantage corp (LFVN) Details

LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. It offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; and Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. The company sells its products primarily through a network of independent distributors, preferred customers, and retail customers in the United States, Japan, Hong Kong, Australia, Mexico, and Canada. It also sells its products online. LifeVantage Corporation is headquartered in Sandy, Utah.

238 Employees
Last Reported Date: 09/12/13

lifevantage corp (LFVN) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $514.5K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $273.1K
Chief Operating Officer
Total Annual Compensation: $346.0K
Chief Product Development Officer
Total Annual Compensation: $300.0K
Chief Network Officer
Total Annual Compensation: $231.1K
Compensation as of Fiscal Year 2013.

lifevantage corp (LFVN) Key Developments

Lifevantage Corporation Presents at 26th Annual ROTH Conference, Mar-11-2014 04:30 PM

Lifevantage Corporation Presents at 26th Annual ROTH Conference, Mar-11-2014 04:30 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Douglas C. Robinson, Chief Executive Officer, President, Director and Member of Strategic Planning Committee.

Lifevantage Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2013; Revises Earnings Guidance for the Year 2014

Lifevantage Corporation reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2013. For the quarter, the company reported net sales of USD 51.538 million compared to USD 53.438 million a year ago. Operating income was USD 5.166 million compared to USD 0.487 million a year ago. Net income before income taxes was USD 4.801 million compared to USD 0.471 million a year ago. Net income was USD 3.282 million compared to USD 0.209 million a year ago. Basic and diluted net income per share was USD 0.03 compared to USD 0.00 a year ago. Non-GAAP adjusted operating income was USD 4.641 million compared to USD 6.437 million a year ago. Non-GAAP adjusted net income was USD 2.936 million or USD 0.03 per diluted share compared to USD 3.801 million or USD 0.03 per diluted share a year ago. For the six months, the company reported net sales of USD 102.866 million compared to USD 106.297 million a year ago. Operating income was USD 10.236 million compared to USD 7.337 million a year ago. Net income before income taxes was USD 9.909 million compared to USD 7.336 million a year ago. Net income was USD 6.538 million compared to USD 4.373 million a year ago. Diluted net income per share was USD 0.06 compared to USD 0.03 a year ago. Non-GAAP adjusted operating income was USD 9.711 million compared to USD 13.287 million a year ago. Non-GAAP adjusted net income was USD 6.192 million or USD 0.05 per diluted share compared to USD 7.965 million or USD 0.06 per diluted share a year ago. The company is updating its annual revenue guidance. The company expects to generate revenue in the range of USD 205 million to USD 220 million in fiscal year 2014 compared to the previous range of USD 225 to USD 235 million. The company is reiterating its previous GAAP operating margin of 9% to 10% and the company is also reiterating its GAAP earnings per diluted share in the range of USD 0.09 to USD 0.11, based on estimated weighted average diluted shares outstanding of 111 million.

Lifevantage Corporation, Q2 2014 Earnings Call, Feb 06, 2014

Lifevantage Corporation, Q2 2014 Earnings Call, Feb 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LFVN:US $1.41 USD 0.00

LFVN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Mannatech Inc $17.47 USD 0.00
Nature's Sunshine Products Inc $14.05 USD +0.38
Reliv International Inc $1.97 USD +0.0499
Tupperware Brands Corp $86.32 USD +0.55
USANA Health Sciences Inc $76.81 USD +0.54
View Industry Companies
 

Industry Analysis

LFVN

Industry Average

Valuation LFVN Industry Range
Price/Earnings 17.1x
Price/Sales 0.7x
Price/Book NM Not Meaningful
Price/Cash Flow 12.5x
TEV/Sales 0.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIFEVANTAGE CORP, please visit www.lifevantage.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.